These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2480354)

  • 1. GH4 pituitary cell variants selected as nonresponsive to thyrotropin-releasing hormone-enhanced substratum adhesion are nonresponsive to epidermal growth factor: evidence for a common signaling defect.
    Ramsdell JS; Tashjian AH
    J Cell Physiol; 1989 Dec; 141(3):565-72. PubMed ID: 2480354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
    Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
    Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhbition of cell proliferation.
    Schonbrunn A; Krasnoff M; Westendorf JM; Tashjian AH
    J Cell Biol; 1980 Jun; 85(3):786-97. PubMed ID: 6771298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity.
    Ramsdell JS; Tashjian AH
    Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin releasing hormone action in pituitary cells. Protein kinase C-mediated effects on the epidermal growth factor receptor.
    Kaji H; Casnellie JE; Hinkle PM
    J Biol Chem; 1988 Sep; 263(27):13588-93. PubMed ID: 2458349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of GH4C1 cell variants to demonstrate a non-spare receptor model for thyrotropin-releasing hormone action.
    Ramsdell JS; Tashjian AH
    Mol Cell Endocrinol; 1985 Dec; 43(2-3):173-80. PubMed ID: 3000850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-dependent calcium channels regulate GH4 pituitary cell proliferation at two stages of the cell cycle.
    Ramsdell JS
    J Cell Physiol; 1991 Feb; 146(2):197-206. PubMed ID: 1705563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-releasing hormone and epidermal growth factor regulate iron-regulatory protein binding in pituitary cells via protein kinase C-dependent and -independent signaling pathways.
    Thomson AM; Rogers JT; Leedman PJ
    J Biol Chem; 2000 Oct; 275(41):31609-15. PubMed ID: 10889193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of pituitary hormone secretion and gene expression by thyrotropin-releasing hormone. A role for mitogen-activated protein kinase signaling cascade in rat pituitary GH3 cells.
    Kanasaki H; Yonehara T; Yamamoto H; Takeuchi Y; Fukunaga K; Takahashi K; Miyazaki K; Miyamoto E
    Biol Reprod; 2002 Jul; 67(1):107-13. PubMed ID: 12080005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of phorbol ester, thyrotropin-releasing hormone, and growth factor stimulation of prolactin gene transcription.
    Murdoch GH; Waterman M; Evans RM; Rosenfeld MG
    J Biol Chem; 1985 Sep; 260(21):11852-8. PubMed ID: 3930485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin-releasing hormone inhibits GH4 pituitary cell proliferation by blocking entry into S phase.
    Ramsdell JS
    Endocrinology; 1990 Jan; 126(1):472-9. PubMed ID: 2104588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanism of EGF receptor activation in pancreatic beta-cells by thyrotropin-releasing hormone.
    Luo L; Yano N; Luo JZ
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E889-99. PubMed ID: 16603724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory effect of pituitary adenylate-cyclase activating polypeptide (PACAP) and its PACAP type I receptor (PAC1R) on prolactin synthesis in rat pituitary somatolactotroph GH3 cells.
    Mijiddorj T; Kanasaki H; Purwana IN; Oride A; Miyazaki K
    Mol Cell Endocrinol; 2011 Jun; 339(1-2):172-9. PubMed ID: 21539889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective thyroliberin-induced prolactin synthesis and release in a hybrid GH strain.
    Brennessel BA; Biswas DK
    Mol Cell Biochem; 1984 Aug; 63(1):67-73. PubMed ID: 6092907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture.
    Dannies PS; Gautvik KM; Tashjian AH
    Endocrinology; 1976 May; 98(5):1147-59. PubMed ID: 177274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor decreases the concentration of thyrotropin-releasing hormone (TRH) receptors and TRH responses in pituitary GH4C1 cells.
    Hinkle PM; Shanshala ED; Yan ZF
    Endocrinology; 1991 Sep; 129(3):1283-8. PubMed ID: 1651844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures.
    Spuch C; Diz-Chaves Y; Pérez-Tilve D; Mallo F
    Endocrine; 2006 Apr; 29(2):317-24. PubMed ID: 16785607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thyrotropin-releasing hormone in prolactin-producing cell models.
    Kanasaki H; Oride A; Mijiddorj T; Kyo S
    Neuropeptides; 2015 Dec; 54():73-7. PubMed ID: 26297348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.
    Kagabu Y; Mishiba T; Okino T; Yanagisawa T
    Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Ca2+-dependent cyclic AMP accumulation and Ca2+ metabolism in intact pituitary tumor cells by modulators of prolactin production.
    Brostrom MA; Brostrom CO; Brotman LA; Green SS
    Mol Pharmacol; 1983 Mar; 23(2):399-408. PubMed ID: 6300649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.